Peter Virsik

Peter Virsik serves as Executive Vice President and Chief Operating Officer at ESSA Pharma. ESSA Pharma operates in the research sector with approximately 27.0 employees. The company is headquartered in Santa Clara, California. ESSA Pharma generates annual revenue of 8841000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Amazon SES Sendgrid Outlook Google Cloud Hosting Remote Render AI

biotechnology: pharmaceutical preparations health care biotechnology research prostate cancer androgen receptor clinical trials masofaniten epi-7386 n-terminal domain ar inhibition small molecule therapy castration-resistant prostate cancer combination therapy antiandrogen resistance novel therapies oncology biopharmaceuticals clinical-stage drug development preclinical studies pharmaceutical research therapeutic targets cancer treatments investigational drugs investor relations pipeline expanded access policy scientific publications treatment outcomes biotechnology molecular targets hormone therapy ar signaling pathway mcrpc antiandrogen therapy drug candidates phase 1 trial phase 2 trial clinical data targeted therapy safe & effective treatments innovative science medical research patient outcomes healthcare biotech drug discovery scientific rigor hyperthermia functional genomics genetic therapies health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Peter Virsik in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ESSA Pharma.

Peter Virsik's Position in the MessageCEO Database

• •Peter Virsik is 1 of 1 verified executive contact we track at ESSA Pharma.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •45 verified contacts work at research companies in the 27.0 employee range (same size as ESSA Pharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Peter Virsik directly?

Peter Virsik's verified email address is available to MessageCEO Pro subscribers. They currently serve as Executive Vice President and Chief Operating Officer at ESSA Pharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Peter Virsik work for?

Peter Virsik is Executive Vice President and Chief Operating Officer at ESSA Pharma, a company in the research sector with 27.0 employees. The company is based in Santa Clara, California.

Can I pitch or sell to Peter Virsik?

As Executive Vice President and Chief Operating Officer at ESSA Pharma, Peter Virsik is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Peter Virsik directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Peter Virsik in?

Peter Virsik works in the research industry as Executive Vice President and Chief Operating Officer at ESSA Pharma. MessageCEO provides verified contact information for executives across all major industries.

Is Peter Virsik's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Peter Virsik's profile is kept up-to-date with the latest available information.

Last updated: June 26, 2026